RPR121056

Overview

RPR121056 ( APC ) is a metabolite of Irinotecan (CPT-11), which is generated by CYP3A4 . Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I , causing cell death, and is widely used in the treatment of colorectal cancer . Irinotecan also directly inhibits AChE .

Application

Products | Products > Disease Areas > Digestive System Cancer | Products > Disease Areas > Cancer | Products > Disease Areas > Digestive System Disease | Products > Disease Areas > Lung Cancer | Products > Disease Areas > Colorectal Cancer | Products > Signaling Pathways > Cell Cycle/DNA Damage | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Topoisomerase | Products > Signaling Pathways > Cholinesterase (ChE)

Product Information

• Catalog No.: HY-100620
• CAS No.: 181467-56-1
• Molecular Formula: C33H38N4O8
• Molecular Weight: 618.68
• Purity: 99.88%
• Storage: Powder -20°C, 3 years ; In solvent -80°C, 6 months , -20°C, 1 month
• Availability: In-stock

Source

Original product source